Abstract
Parkinson's disease (PD) is a neurodegenerative disorder that significantly alters the motor capacity, mood and quality of life of the individual. Current pharmacological therapy focuses on the management of symptoms, so art therapy, highlighting clay, has recently been proposed as a non-pharmacological adjuvant therapy to attenuate many of the clinical manifestations of the disease. For this reason, the main objective was to evaluate the recent scientific evidence on the effect of art therapy with clay on motor, affective and behavioral functions in patients with PD. To achieve this, a bibliographic search was carried out in the databases PubMed, ProQuest, EBSCO host, Scielo, Elsevier, Science direct and Scholar Google, using as keywords "Parkinson's disease" and "clay art therapy" and the Boolean operator 'AND". Studies published between January 2008 and December 2019 were considered and, after establishing the inclusion criteria, 4 studies were eligible. This review demonstrates the beneficial effect of clay art therapy as a complementary non-pharmacological approach to improve affective and behavioral functions (depression, anxiety, obsessive-compulsive thoughts, phobia and distress) of people with PD. However, the scales implemented in the selected studies are not sufficient to assess a significant impact on the motor state or manual dexterity of the patients, as well as its effect on the symptoms according to the stage of the disease. For this reason, it is necessary to expand research in this field in order to establish more conclusively the global effect that the artistic intervention of clay manipulation produces on this pathology.
References
Chou K. Clinical manifestations of Parkinson's disease [Internet]. UpToDate. 2020 [citado 2020 Jun 12]. Disponible en: Disponible en: https://www.uptodate.com/contents/clinical-manifestations-of-parkinson-disease#:~:text=The%20cardinal%20 features%20of%20PD,PD%20%5B6%2D9%5D
.
Jankovic J. Etiology and pathogenesis of Parkinson disease. Neurol Clin. 2009;27(3):583-603. doi: 10.1016/j.ncl.2009.04.004.
Kouli A, Torsney KM, Kuan WL. Chapter 1. Parkinson's disease: Etiology, neuropathology, and pathogenesis [Internet]. NCBI; 2018 [citado 2020 Jun 15]. Disponible en: Disponible en: https://wwwncbi.nlm.nih.gov/books/NBK536722/
Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017;124(8):901-5. doi: 10.1007/s00702-017-1686-y.
Capriotti T, Terzakis K. Parkinson disease [Internet]. Home Healthc Now. 2016;34(6):300-7. doi: 10.1097/NHH.0000000000000398.
Hayes MT. Parkinson's disease and parkinsonism. Am J Med. 2019;132(7):802-7. doi: 10.1016/j.amjmed.2019.03.001.
Reich SG, Savitt JM. Parkinson's disease. Med Clin North Am. 2019;103(2):337-50. doi: 10.1016/j.mcna.2018.10.014.
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson's disease. MDS. 2015;30(12):1591-601. doi: 10.1002/mds.26424.
Gultekin BK, Ozdilek B, Bestepe EE. Social phobia in Parkinson's disease: Prevalence and risk factors. Neuropsychiatr. 2014;10:829-34. doi: 10.2147/NDT.S62942.
Hanagasi HA, Tufekcioglu Z, Emre M. Dementia in Parkinson's disease. J Neurol. 2017;374:26-31. doi: 10.1016/j.jns.2017.01.012.
Ashraghi MR, Pagano G, Polychronis S, Niccolini F, Politis M. Parkinson's disease, diabetes and cognitive impairment. Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):11-21. doi: 10.2174/1872214810999160628105549.
Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18(7):435-50. doi: 10.1038/nrn.2017.62.
Smeltere L, Kuznecovs V, Erts R. Depression and social phobia in essential tremor and Parkinson's disease. Brain Behav. 2017;7(9):e00781. doi: 10.1002/brb3.781.
Elkis-Abuhoff DL, Gaydos M. Medical art therapy research moves forward: A review of clay manipulation with Parkinson's disease. Art Ther. 2018;35(2):68-76 doi: 10.1080/07421656.2018.1483162.
Li S, Dong J, Cheng C, Le W. Therapies for Parkinson's diseases: alternatives to current pharmacological interventions. J Neural Transm (Vienna). 2016;123(11):1279-99. doi: 10.1007/s00702-016-1603-9.
American Art Therapy Association, Research Committee; Backos A, Betts D, Bermudez-Rodriguez D, Collie K, Deaver S, Gerber N, et al. Art therapy outcome bibliography [Internet]. 2013 [citado 2020 Jun 15]. Disponible en: Disponible en: http://www.arttherapy.org/upload/outcomebibliographyresearchcmte.pdf
Pratt RR. Art, dance, and music therapy. Phys Med Rehabil Clin N Am. 2004;15(4):827-41. doi: 10.1016/j.pmr.2004.03.004.
Pratt RR. Art, dance, and music therapy. Phys Med Rehabil Clin N Am. 2004;15(4):827-41. doi: 10.1016/j.pmr.2004.03.004.
Abramowitz K The unstructured use of clay in art therapy with older adults. Can Art Ther Assoc J. 2013;26:1-12. doi: 10.1080/08322473.2013.11415574.
Timmons A, MacDonald E. "Alchemy and magic": The experience of using clay for people with chronic illness and disability. Br J Occup Ther. 2008;71(3):86-94. doi: 10.1177/030802260807100302.
Rugh MM. Art therapy with the institutionalized older adult [Internet]. Act Adapt Aging. 1985;6:105-20. doi: 10.1300/J016v06n03_18.
Orr PR. Treating the whole person: A combination of medical and psychiatric treatment for older adults. Art Ther. 1997;14(3):200-5. doi: 10.1080/07421656.1987.10759282.
Sholt M, Gavron T. Therapeutic qualities of clay-work in art therapy and psychotherapy: a review. Art Ther. 2006;23(2):66-72. doi: 10.1080/07421656.2006.10129647.
Guseva E. Art therapy in dementia care: toward neurologically informed, evidence-based practice. Art Ther. 2019;36(1):46-9. doi: 10.1080/07421656.2019.1564613.
Nolan E. A review of "Beyond self-care for helping professionals: the expressive therapies continuum and the life enrichment model". Art Ther. 2019;36(1). doi: 10.1080/07421656.2019.1579532.
Wadeson H. Art as therapy for Parkinson's disease. Art Ther. 2003;20(1):35-38. doi: 10.1080/07421656.2003.10129636.
Cucca A, Acosta I, Berberian M, Lemen AC, Rizzo JR, Ghilardi MF, et al. Visuospatial exploration and art therapy intervention in patients with Parkinson's disease: an exploratory therapeutic protocol. Complement Ther Med. 2018;40:70-76. doi: 10.1016/j.ctim.2018.07.011
Hoffmann N. Using art therapy to address cognitive symptoms of Parkinson's disease. Tallahassee, FA: Florida State University; 2011.
Lauring JO, Ishizu T, Kutlikova HH, Dorflinger F, Haugbol S, Leder H, et al. Why would Parkinson's disease lead to sudden changes in creativity, motivation, or style with visual art: A review of case evidence and new neurobiological, contextual, and genetic hypotheses. Neurosci Biobehav Rev. 2019;100:129-65. doi: 10.1016/j.neubiorev.2018.12.016.
Bae YS, Kim DH. The applied effectiveness of clay art therapy for patients with Parkinson's disease. J Evidence-Based Integr Med. 2018;23:2515690X18765943. doi: 10.1177/2515690X18765943.
Elkis-Abuhoff DL, Goldblatt RB, Gaydos M, Corrato S. Effects of clay manipulation on somatic dysfunction and emotional distress in patients with Parkinson's disease. Art Ther. 2008;25(3):122-8. doi: 10.1080/07421656.2008.10129596.
Elkis-Abuhoff DL, Goldblatt RB, Gaydos M, Convery C. A pilot study to determine the psychological effects of manipulation of therapeutic art forms among patients with Parkinson's disease. Int J Art Ther. 2013;18(3):113-21. doi: 10.1080/17454832.2013.797481.
Goldblatt R, Elkis-Abuhoff D, Gaydos M, Napoli A. Understanding clinical benefits of modeling clay exploration with patients diagnosed with Parkinson's disease. Arts Health. 2010;2(2):140-8. doi: 10.1080/17533010903495405.
Strand S, Waller D. The experience of Parkinson's: Words and images through art therapy-a pilot research study. Int J Art Ther Inscape. 2010;15(2):84-93. doi: 10.1080/17454832.2010.524890.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.